Vasudevan Anil, Phadke Kishore, Yap Hui-Kim
Department of Pediatric Nephrology, St. John's Medical College Hospital, Bengaluru, Karnataka, India, 560034.
Rainbow Children's Hospital, Bengaluru, India.
Pediatr Nephrol. 2017 Jul;32(7):1145-1156. doi: 10.1007/s00467-016-3482-6. Epub 2016 Oct 28.
Renal replacement therapy (RRT) is the most important supportive measure used in the management of acute kidney injury (AKI). Peritoneal dialysis (PD) is a safe, simple and inexpensive procedure and has been used in pediatric AKI patients, ranging from neonates to adolescents. It is the modality of choice for RRT in developing countries with cost constraints and limited resources. However, its use has declined with the availability of newer types of extracorporeal modalities for RRT in the developed world. Much controversy exists regarding the dosing and adequacy of PD in the management of AKI. Data in infants and children have shown that PD can provide adequate clearance, ultrafiltration and correction of metabolic abnormalities even in those who are critically ill. Although there are no prospective studies in children, data from retrospective studies reveal no differences in mortality rates between different modalities of RRT. In this review, we discuss the advantages and limitations of PD, indications for acute PD, strategies to improve the efficiency of acute PD and outcomes of PD in children with AKI.
肾脏替代治疗(RRT)是用于急性肾损伤(AKI)管理的最重要的支持性措施。腹膜透析(PD)是一种安全、简单且廉价的治疗方法,已用于从新生儿到青少年的儿科AKI患者。在资源有限且成本受限的发展中国家,它是RRT的首选方式。然而,随着发达国家出现新型体外RRT模式,其使用有所减少。关于PD在AKI管理中的剂量和充分性存在很多争议。婴幼儿和儿童的数据表明,即使在危重病患儿中,PD也能提供足够的清除率、超滤并纠正代谢异常。虽然儿童中没有前瞻性研究,但回顾性研究的数据显示不同RRT模式之间的死亡率没有差异。在本综述中,我们讨论了PD的优缺点、急性PD的适应症、提高急性PD效率的策略以及AKI患儿接受PD的结局。